Olympiad Research LP Acquires New Holdings in Aspen Aerogels, Inc. (NYSE:ASPN)

Olympiad Research LP acquired a new stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 24,007 shares of the construction company’s stock, valued at approximately $285,000.

Other institutional investors also recently added to or reduced their stakes in the company. Lord Abbett & CO. LLC bought a new stake in Aspen Aerogels during the third quarter valued at about $10,126,000. Oppenheimer & Co. Inc. boosted its holdings in Aspen Aerogels by 167.2% in the third quarter. Oppenheimer & Co. Inc. now owns 102,535 shares of the construction company’s stock worth $2,839,000 after acquiring an additional 64,154 shares in the last quarter. Sanders Morris Harris LLC boosted its holdings in Aspen Aerogels by 337.5% in the fourth quarter. Sanders Morris Harris LLC now owns 35,000 shares of the construction company’s stock worth $436,000 after acquiring an additional 27,000 shares in the last quarter. Penserra Capital Management LLC acquired a new stake in Aspen Aerogels in the third quarter worth about $1,342,000. Finally, Geode Capital Management LLC boosted its holdings in Aspen Aerogels by 5.7% in the third quarter. Geode Capital Management LLC now owns 1,385,968 shares of the construction company’s stock worth $38,385,000 after acquiring an additional 75,024 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Stock Down 1.4 %

Shares of ASPN stock opened at $8.04 on Friday. The stock has a 50 day moving average of $11.65 and a 200 day moving average of $18.07. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The stock has a market cap of $659.27 million, a P/E ratio of 50.22 and a beta of 2.14. Aspen Aerogels, Inc. has a twelve month low of $7.96 and a twelve month high of $33.15.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. As a group, sell-side analysts expect that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. Roth Mkm lowered their price target on Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating for the company in a report on Friday, February 14th. StockNews.com raised Aspen Aerogels to a “sell” rating in a report on Wednesday. Seaport Res Ptn downgraded Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 12th. Canaccord Genuity Group reduced their price objective on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating for the company in a research note on Friday, February 14th. Finally, Barclays reduced their price objective on Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating for the company in a research note on Wednesday. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $22.44.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.